CLPT
Clearpoint Neuro Inc
15.00$
-5.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.2% | 41.1% | 40.8% | 36.5% | 40.3% | 38.7% | 39.5% | 39.7% | 36.8% | 38.5% | 37.8% | 36.4% | 37.4% | |
| 56.8% | 58.9% | 59.2% | 63.5% | 59.7% | 61.3% | 60.5% | 60.3% | 63.2% | 61.5% | 62.2% | 63.6% | 62.6% | |
| 42.2% | 38.9% | 34.4% | 39.7% | 40.8% | 42.9% | 39.8% | 41.6% | 39.0% | 31.1% | 37.3% | 42.6% | 37.5% | |
| 50.3% | 39.9% | 37.2% | 35.3% | 38.8% | 41.6% | 48.1% | 36.8% | 36.0% | 56.1% | 41.2% | 51.0% | 46.3% | |
| 141.8% | 128.0% | 114.6% | 123.8% | 123.4% | 133.4% | 133.1% | 121.9% | 122.7% | 129.2% | 132.1% | 157.7% | 136.0% | |
| -85.0% | -69.1% | -55.4% | -60.3% | -63.7% | -72.1% | -72.6% | -61.6% | -59.5% | -67.7% | -69.9% | -94.2% | -73.4% | |
| – | 2.8% | – | – | – | – | 0.0% | 0.9% | 6.1% | 6.8% | 11.4% | 13.0% | 9.6% | |
| -83.5% | -67.8% | -54.3% | -56.1% | -61.2% | -69.3% | -70.8% | -63.1% | -66.4% | -74.8% | -78.7% | -104.5% | -81.8% | |
| -7.3% | 10.6% | 0.2% | – | – | -5.5% | 0.2% | 0.3% | 0.1% | 0.0% | 0.1% | -0.3% | 0.0% | |
| -83.5% | -67.8% | -54.3% | -56.1% | -61.2% | -69.3% | -71.0% | -63.3% | -66.5% | -74.8% | -78.8% | -104.2% | -81.8% | |
| -76.1% | -61.6% | -48.1% | -50.2% | -55.1% | -63.2% | -66.9% | -55.4% | -59.5% | -59.8% | -58.1% | -81.5% | -64.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.